AHEPA University Hospital Report issue

Academic/Hospital Phase 3
Founded: Thessaloniki Greece (1947)

Organization Overview

First Clinical Trial
2014
NCT03560804
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

1st Internal Medicine Department, AHEPA University Hospital | Hypertension Excellence Center, 1st Department of Internal Medicine, AHEPA University Hospital

Active Ingredients

Drugs in Phase 3 Trials (1)

metformin (glucophage) (1 trial)

Drugs in Other Trials (2)

chlorthalidone (Hygroton) (1 trial)

olmesartan (benicar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 1 (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3